ha 1004 has been researched along with nicardipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Hidaka, H; Ikegaki, I; Kageyama, N; Okada, T; Shibuya, M; Suzuki, Y | 1 |
| Asano, T; Hidaka, H | 1 |
2 other study(ies) available for ha 1004 and nicardipine
| Article | Year |
|---|---|
Effect of the intracellular calcium antagonist HA1004 on cerebral blood flow in rats.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Intracellular Fluid; Isoquinolines; Male; Nicardipine; Rats; Rats, Inbred Strains; Sulfonamides | 1988 |
Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Coronary Circulation; Dogs; Heart Ventricles; Hemodynamics; In Vitro Techniques; Isoquinolines; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Renal Artery; Renal Circulation; Sulfonamides; Ventricular Function | 1985 |